Fulcrum Therapeutics FULC
NASDAQ FULC
$3.68 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Fulcrum Therapeutics (FULC) EV to CFO (2025)

Updated

Fulcrum Therapeutics' (FULC) EV to CFO came in at 14.51 for Q1 2025.

Analysis

Fulcrum Therapeutics (FULC) EV to CFO (2025) Analysis & Trends

For the trailing twelve months through Mar 31, 2025, EV to CFO at Fulcrum Therapeutics was -13.35.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Fulcrum Therapeutics 280.27 Mn -63.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 14.51
API Access

Fulcrum Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=FULC&period=max&api_key=YOUR_API_KEY